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original work is propObjective: To determine the uptake of home-based HIV counselling and testing (HCT)
in four communities of the HPTN 071 (PopART) trial in Zambia among adolescents aged
15–19 years and explore factors associated with HCT uptake.
Design: The PopART for youth study is a three-arm community-randomized trial in 12
communities in Zambia and nine communities in South Africa which aims to evaluate
the acceptability and uptake of a HIV prevention package, including universal HIV
testing and treatment, among young people. The study is nested within the HPTN 071
(PopART) trial.
Methods: Using a door-to-door approach that includes systematically revisiting house-
holds, all adolescents enumerated were offered participation in the intervention and
verbal consent was obtained. Data were analysed from October 2015 to September
2016.
Results: Among 15 456 enumerated adolescents, 11 175 (72.3%) accepted the inter-
vention. HCT uptake was 80.6% (8707/10 809) and was similar by sex. Adolescents that
knew their HIV-positive status increased almost three-fold, from 75 to 210. Following
visits from community HIV care providers, knowledge of HIV status increased from
27.6% (3007/10 884) to 88.5% (9636/10 884). HCT uptake was associated with
community, age, duration since previous HIV test; other household members accepting
HCT, having an HIV-positive household member, circumcision, and being sympto-
matic for STIs.
Conclusion: Through a home-based approach of offering a combination HIV preven-
tion package, the proportion of adolescents who knew their HIV status increased from
28 to 89% among those that accepted the intervention. Delivering a community-level
door-to-door combination, HIV prevention package is acceptable to many adolescents
and can be effective if done in combination with targeted testing.
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AIDS is the leading cause of death among adolescents in
Sub-Sahara Africa (SSA), and the second most common
cause of death among adolescents globally [1]. An
estimated 2.1 million adolescents aged 10–19 years are
living with HIV globally [2], the majority of these in SSA,
including 79 000 in Zambia [2–4]. More than 250 000
adolescents aged 15–19 year old were newly infected
with HIV in 2013, with girls accounting for two out of
three of these new infections globally and eight out
of 10 in SSA [1]. The vast majority of adolescents in
Africa, including those already infected with HIV,
do not know their HIV status [5,6]. In SSA, only 13%
of adolescent girls and 9% of adolescent boys aged
15–19 have tested for HIV and received their results
in the previous 12 months [7]. Without current
knowledge of HIV status, the subsequent steps in the
HIV treatment cascade cannot be accessed [2,8].
Although antiretroviral therapy (ART) has dramatically
improved survival for people living with HIV, clinical
outcomes of HIV-positive adolescents fall behind adults, a
consequence of poor knowledge of status and lack of
access to therapy [4].
Uptake of HIV counselling and testing (HCT) among
adolescents in Zambia remains low [9]. According to the
latest Zambia Demographic Health Survey (2013–2014)
report, sexually active female adolescents were more
likely to have tested for HIV in the previous 12 months
compared with their males counterparts (49.7 versus
26.9%) [9]. It is often more difficult for young people to
seek HCT compared with adults, partly limited by the
need in Zambia for all adolescents under the age of
16 years to gain parental or guardian consent prior to
testing [10]. Additional barriers include fear of a positive
test, stigma, association of HCTwith high-risk behaviour,
lack of information, perceived risk with respect to sexual
exposure, poor attitudes of healthcare providers, and
difficulty accessing testing services [4,9,11–18]. Such
challenges result in underutilization of HCT services
which subsequently leads to late diagnosis, delayed
initiation of ART, poorer health outcomes, and increased
transmission [4,19].
Offering home-based HCT (HB-HCT) is an important
strategy for increasing HCT coverage particularly among
individuals who do not use health services regularly such
as adolescents [4]. Although community-based biome-
dical prevention approaches that include HCT have
proven effective for the general population, these have
remained as pilot projects for adolescents with limited
evidence in SSA [20]. Robust implementation research
studies are needed to provide new knowledge to improve
programming and policy for highly accessible HIV testing
and care, such as community-based interventions to
increase adolescent HCT [21].The HPTN 071 trial, also known as PopART
(Population Effects of Antiretroviral Therapy to reduce
HIV Transmission) is a three-arm community rando-
mized trial in 12 communities in Zambia and nine
communities in South Africa evaluating the impact of a
combination HIV prevention package, including uni-
versal HIV testing and treatment (UTT), on community-
level HIV incidence [12]. Within this study is an adolescent
substudy calledPopART for youth (P-ART-Y) which aims
to determine the impact of the community-level HIV
combination prevention packages on HIV prevalence over
26 months in adolescents aged 15–19 years. It will also
assess the need for specific youth-targeted interventions in
the context of community-wide UTT.
We report results and explore factors associated with
HCTuptake by adolescents aged 15–19 years in four arm
A communities in Zambia who are offered a ‘full’
combination HIV prevention package that includes UTT
through a door-to-door approach from the P-ART-Y
study. These are initial results from arm A communities
only after the first 11 months of study commencement.
We acknowledge that this is early data. However, there is a
strong case to be made to share lessons in real time to
inform policymakers and funders, hence supporting
timely reporting of outcomes relevant to national and
global delivery of testing and care.Methods
Trial design and setting
HPTN 071 (PopART): The main trial is a cluster
randomised trial being implemented in 21 high HIV
prevalent communities in Zambia and South Africa [22].
The 21 communities were divided into seven triplets.
Each triplet was defined as a set of three communities
with similarities in geography, size, and estimated baseline
HIV prevalence. Each community in a triplet was then
randomly assigned to one of three arms; arm A receiving
the full PopART intervention including HCT and
universal ART for all HIV positives, arm B receiving
the full PopART intervention with ART provided
according to national guidelines, and arm C being the
control arm. Further details of the trial are described
elsewhere [22].
The P-ART-Y study is nested within the main HPTN
071 (PopART) trial; it is being implemented in 12
communities in Zambia and nine communities in the
Western Cape Province of South Africa [22,23]. A
community is defined as the catchment population of a
local health unit (through which the intervention is
delivered), including all schools in the selected area. The
P-ART-Y study has three phases: qualitative baseline
studies and collection of process data from the ongoing
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targeted interventions in communities (phase 2); and an
epidemiological survey to determine the effect of the
intervention on the knowledge of HIV status (phase 3).
We report on the adolescent population aged 15–19 years
from the four arm A communities in Zambia using
phase 1 data.
The study intervention
The PopART combination HIV prevention package is
delivered by trained community health workers called
community HIV care providers (CHiPs) via a door-to-
door approach, with treatment and care related services
provided by local government clinics [22]. The inter-
vention is offered in the four arm A communities and is
delivered in annual rounds. CHiPs teams enumerate (list)
all household members in the community including those
absent, irrespective of age. They offer HCT, support for
linkage to care of all identified HIV-positive individuals,
ART adherence support, referral of HIV-negative males
for voluntary medical male circumcision (VMMC), as
well as tuberculosis (TB) and Sexually transmitted
infections (STI) screening. CHiPs work in pairs within
an allocated zone (consisting of 450–500 households) of a
community and throughout the period, arrange repeat
household visits to monitor linkage to services and offer
HCT for those absent at previous visits.
CHiPs are selected by a formal process from a cadre of
existing community health workers/volunteers which
involves the communities. They are selected based on
availability, residence in community, gender balance (58%
are women), and age (median age 37 years). They receive
continuous training by experienced facilitators in
counselling, participatory facilitation, mentoring and
follow-up, and are supported by supervisory staff who
routinely visit households to check their performance.
Informed consent
To participate in the PopART intervention, all household
members aged 18 year and older are asked for verbal
informed consent, whereas those younger than 18 are
asked for their assent and their parents’ consent. Consent
to participate does not necessarily include consent to
HCT, although this is encouraged. For HCT, according
to national guidelines, those 16 years and older are asked
for written consent, and those under 16 years for their
parent’s written consent.
Individual written consent for other interventions such as
VMMC is obtained using standard procedures as these are
considered part of the routine delivery of HIV prevention
services and not specifically study related.
HIV counselling and testing
HCT is offered to all household members, those who
agree have the option to receive HCT as couples, ahousehold group or individually. HIV testing is
conducted according to the Zambian national algorithm
that uses Alere Determine HIV-1/2 test (Alere Inter-
national Limited, Japan) as a screening test and the
Unigold HIV test (Trinity Biotech Manufacturing Ltd,
Bray, Ireland) as the confirmatory test for individuals who
have a reactive result on the screening test. Individuals
with discordant screening and confirmatory tests have
repeat tests immediately and repeated after 2 weeks if
results are still discordant.
Data collection and analysis
In the main trial, the intervention has been offered to all
household members 18 years and older since December
2013. Data is recorded in an electronic data capture
device. Collection of additional data on the uptake of the
intervention for those under 18 years began in October
2015 following ethical approvals. We report on data
collected from October 2015 to September 2016 for
adolescents aged 15–19 years from four arm A
communities in Zambia. Arm A communities only were
included in this analysis as they all received the same
combination prevention package and no comparisons
with standard of care communities was done.
Univariable and multivariable random-effects logistic
regression was used to estimate unadjusted odds ratio
(OR) and adjusted (aOR), with all analysis controlled for
community. Analysis was done separately for males and
females, with zone as a random effect to account for
clustering because of variation in CHiPs’ performance.
Association between HCT uptake and variables that
include age, sex, community, time since previous HIV
test and presence of young or older adults in the
household was explored. The likelihood ratio test was
used to compare the fit of different models and quantify
evidence of associations between individual character-
istics and HCT uptake. In multivariable models, age
group and prior history of HCT were considered for
inclusion first, and confounding among community, age
group, and previous history of HCT was explored.
Following this, other factors were considered and those
found to be association with the outcome (P< 0.10) in
multivariable analysis were included. Analysis was
restricted to individuals with complete data.
Knowledge of HIV status before the intervention was
defined as self-reported HIV positive or self-report to
have tested HIV negative in the previous 12 months.
Knowledge of HIV status after intervention was defined
as self-reported HIV positive, tested by CHiPs or tested
HIV negative elsewhere in the previous 12 months.
Comparison of knowledge of HIV status by age and sex
was done as these are widely acknowledged risk factors
[24].
To calculate HIV-prevalence, we assumed that all ado-
lescents who knew their HIV-positive status self-reported
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46,762 HH counted in HH census
1,267 HH refused/absent (2.8%)
201,826 HH members 
136,448 HH members 
enumerated aer October 1, 
43,008 HH enumerated (96.9%)
44,364 HH consented (97.2%)
45,631 HH visited by CHiPs 
65,378 HH members enumerated before October 1, 2015 
(32.4%)
1,356 HH not enumerated (3.1%)
4,423 had health data recorded
4,548 males accepted the intervenon 
(40.7%) 125 no health data 
recorded (2.7%)
874 declined HCT 
(19.9%)
3,526 accepted HCT (80.1%)
4,400 eligible for tesng (99.5%)
23 self-reported 
HIV+ (0.5%), 22 in 
care, 20 on ART
21 HIV+ (0.6%)
3,505 HIV- (99.4%)
15,456 HH members aged 15-19 
years enumerated (11.3%)
52,451 HH members aged 0-14 years enumerated (38.4%) 
68,541 HH members aged ≥20 years enumerated (50.2%)
3,908 absent (25.3%), 277 refused (1.8%), 96 pending 
(0.6%)
11,175 HH members aged 15-19 
years accepted the intervenon 
(72.3%)
6,461 had health data recorded (97.5%)
6,627 females accepted the intervenon 
(59.3%) 166 no health 
data recorded 
1,228 declined 
HCT (19.2%)
5,181 accepted HCT (80.8%)
6,409 eligible for tesng (99.2%)
52 self-reported 
HIV+ (0.8%), 43 in 
care, 41 on ART
114 HIV+ (2.2%)
5,067 HIV- (97.8%)
Males Females
Fig. 1. Flow chart showing study intervention participation and HIV-testing eligibility. ART, antiretroviral therapy; CHiPs,
community HIV care providers; HCT, HIV counselling and testing; HH, household.this to the CHiPs and that the proportion of HIV
positives in those not accepting testing was the same as
those accepting testing. HIV prevalence was defined as
the sum of self-reported HIV positive, tested positive by
CHiPs and those estimated to be HIV positive among
those declining testing, divided by the number of
adolescents consenting.
To calculate the United Nations Programme on HIV/
AIDS (UNAIDS) ‘first 90’ among consenters and the
population we assumed that all consenting adolescents
who knew HIV-positive status, self-reported this to the
CHiPs; the proportion of HIV positives who knew their
status was similar in those not consenting as in those
consenting (at time of CHiPs visit); the proportion of
those testing HIV positive among those accepting testing
by CHiPs was the same in those consenting to the
intervention but declining testing and those estimated to
be eligible for HIV testing in the group not consenting to
the intervention. The ‘first 90 before the intervention’
defines those who knew their HIV-positive status among
those estimated to be HIV positive before the CHiPs’
visit. The ‘first 90 after the intervention’ defines the same
but immediately after the CHiPs’ visit and includes the
impact of HCT.
Ethical approval
Ethics approval was obtained from the ethics committees
of the University of Zambia and the London School of
Hygiene and Tropical Medicine. Permission to conduct
the study was received from the Ministry of Health.Results
Participation
From June 2015 to September 2016, 97.6% (45 631/
46 762) of the total households were visited by CHiPs
(Fig. 1). Enumeration of households was completed
for 94.2% (43 008/45 631) and average household size
was 4.7 individuals (201 826 members in 43 008 house-
holds).
In total, 15 456 adolescents aged 15–19 were enumerated
and 277 (1.8%) refused to participate in the intervention.
Refusal was highest among the 18-year olds (95/3,450;
2.8%). Refusal was higher in males than females (150/
6957; 2.2% versus 127/8499; 1.5%). CHiPs were not able
to contact 3,908/15,456 (25.3%) adolescents. For males
31.9% (2,219/6,957) could not be contacted and for
females 19.9% (1689/8499). 15-year olds adolescents
were more difficult to contact (1036/2786; 37.2%) than
older ages.
A total of 72.3% (11 175/15 456) adolescents accepted the
intervention (40.7% (4548/11 175) males; 59.3% (6627/
11 175) females). For 10 884/11 175 (97.4%) adolescents,
health data was electronically recorded after accepting the
intervention. In total 75/10 884 (0.7%) adolescents self-
reported to be HIV positive; leaving 10 809 adolescents
eligible for HIV testing (Fig. 1). Of the self-reported HIV
positives, more males than females were linked to care
(22/23 males, 95.6%; 43/52 females, 82.7%). Most
adolescents were on ART (20/22 males, 90.9%; 41/43
females, 95.3%).
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0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Total male 15 16 17 18 19 Total female 15 16 17 18 19
Known status before: self-report HIV-posive or tested for HIV elsewhere within previous 12 months
Known status aer: self-report HIV+ or tested by CHiPs or tested for HIV elsewhere within previous 12 months
MALE FEMALE
Fig. 2. Knowledge of HIV-status before and after the intervention by age and sex.HIV counselling and testing uptake
Overall 80.6% (8707/10 809) adolescents accepted HIV
testing by the CHiPs. HCT uptake was similar by sex
(80.8% females; 80.1% males; Fig. 1). Main reasons for
refusing testing varied per age. Among younger age
groups the main reason for refusal was ‘not considered at
risk’ (37% in 15-year old males; 32% in 15-year old
females), whereas among older adolescents ‘recently
tested’ was the main reason for refusal (35% in 19-year old
males; 44% in 19-year old females). On average about
19% of decliners gave ‘other’ reasons for refusing to be
tested, 15% were ‘too busy’, 11% did not give a reason and
some feared the result of the test (1.5%) or the finger prick
(1.5%) (Data not shown).
Over half of the adolescents had never been tested for
HIV before [60.6% (2665/4400) males and 53.1% (3406/
6409) females]. There was a trend between age and
potential first time testers whereby younger adolescents
were less likely to have tested before compared with older
ones [79.8% (1304/1634) never tested in 15-year olds and
30.3% (846/2790) in 19-year olds].
Of consenting adolescents, 27.6% (3007/10 884) knew
their HIV status before the intervention and 88.6%
(9636/10 884) after the intervention. For males, the
increase was from 22.3% (986/4423) to 87.6% (3876/
4423); for females from 31.3% (2021/6461) to 89.1%
(5760/6461; Fig. 2). The highest impact of the
intervention in terms of knowing one’s HIV status was
among 16-year old males (16.5% before to 85.0% after the
intervention) and 16-year old females (19.7% before to
85.6% after the intervention).
Factors associated with HIV counselling and
testing uptake
In univariable analysis, factors associated with HCT
uptake were community, age, time since previous HIV
test, having at least one adult in the household previously
tested by CHiPs, and being symptomatic for STIs (Table1). Additionally, for males, circumcision was associated
with HCT uptake, whereas for females having a known
HIV-positive young adult (aged 20–34) in the household
was associated with HCTuptake. These associations were
maintained in the multivariable analysis, with the
exception of STI symptoms among males.
Older adolescents aged 17–19 had more than two-fold
higher odds of accepting HCT than 15-year olds. Also
16-year olds were more likely to accept HCT than 15-
year olds but the effect was less pronounced [aOR: 1.42,
95% confidence interval (CI) 1.08–1.87 males; 1.69, 95%
CI 1.35–2.13 females).
There was no difference observed in HCT uptake in
communities Z2, Z10, and Z8. In community Z5,
adolescents had three-fold higher odds of accepting HCT,
compared with community Z8 (aOR: 2.90, 95% CI:
1.77–4.75 males; 2.80, 95% CI 1.81–4.34 females).
Adolescents, recently, tested for HIV had the lowest odds
of HCT uptake compared with those who never tested
(aOR: 0.11, 95% CI 0.08–0.15 males; 0.20, 95% CI
0.17–0.25 females).
Adolescents living in households with additional one or
more young (aged 20–34 years) or older (aged35 years)
adult previously tested by CHiPs had higher odds of
accepting HCT compared with households with no
household member previously tested by CHiPs (Table 1).
Additionally, in females, having an HIV-positive house-
hold member (young or older adult) in the same
household was associated with higher HCT uptake
(aOR: 1.60, 95% CI 1.21–2.12).
There was weak evidence that HCTuptake was associated
with being symptomatic for STI (OR: 5.62, 95% CI
0.73–43.30 in males and 4.97, 95% CI 1.52–16.25 in
females) and TB (OR: 2.67, 95% CI 0.54–13.09 in males
and 2.83, 95% CI 0.65–12.43 in females) in univariable
analysis. However, there was moderate evidence for an
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.association for STI symptomatic females in multivariable
analysis (aOR 4.62, 95% CI 1.38–15.50). VMMC was
associated with slightly higher HCT uptake (aOR: 1.38,
95% CI 1.15–1.68), whereas traditional circumcision was
weakly associated with lower HCT uptake (aOR: 0.68;
95%CI: 0.42–1.10), compared with no circumcision.
Proportion of HIV positives among those who
consented
Self-reported HIV positives
Overall 0.5% (23/4423) of males and 0.8% (52/6461) of
females self-reported to be HIV positive, varying by
community and age (Table 2 and Table 3). Female
adolescents self-reporting to be HIV positive increased
with age, whereas this was less pronounced in males. Most
adolescents who self-reported to be HIV positive stated to
have been last tested more than 12 months ago (23/23
males and 33/52 females).
Newly diagnosed HIV positives
Of all adolescents aware of their HIV positive status after
the intervention, 47.7% (21/44) of males and 68.7%
(114/166) of females were diagnosed by CHiPs. The
biggest attribution was made in females aged 17 and 18
years, where over 80% of the known HIV positives were
diagnosed by CHiPs (Tables 2 and 3). The number of
adolescents known to have HIV increased from 75 (23
males; 52 females) to 210 (44 males; 166 females) (Tables 2
and 3). The relative benefit for the intervention varied
between communities.
HIV prevalence
Overall HIV prevalence among consenters was higher in
females than males (3.0% compared with 1.1%). As
expected, the highest prevalence was found in those with
symptoms suggestive of TB and STI for females.
‘First 90’
All HIV-positive male adolescents’ consenters reached the
‘first 90’ after the intervention except for the 15-year olds,
whereas in females proportions were approaching the first
90 across all ages. The ‘first 90’ in the population was not
equally reached in both sexes (Fig. 3 a and b).Discussion
Uptake of home-based HIV counselling and
testing
The study has shown that after almost 1 year of delivering
a HB-HCT approach, the proportion of 15–19-year old
adolescents who know their HIV status tripled from 27.6
to 88.6%, approaching the target goal of 90%. To our
knowledge, this study is the first community-based
population intervention of this size that demonstrates
the feasibility of delivering HB-HCT for adolescents
aged 15–19 years in SSA. We show that in a high
S228 AIDS 2017, Vol 31 (Suppl 3)
Table 2. Self-reported HIV-positive and newly HIV positive identified by community HIV care providers in adolescent males.
Characteristic
Total consented
to intervention
Self-reported
HIVþ
Tested
HIVþ
Known HIVþ after
the intervention
Proportion of HIVþ
diagnosed by CHiPs
HIV prevalence
among consenters
Total 4423 23 21 44 47.7% 1.1%
Community
Z2 588 5 4 9 44.4% 1.7%
Z5 1207 0 7 7 100.0% 0.6%
Z8 1994 12 8 20 40.0% 1.1%
Z10 634 6 2 8 25.0% 1.4%
Age
15 685 4 6 10 60.0% 1.8%
16 831 2 1 3 33.3% 0.4%
17 751 6 3 9 33.3% 1.3%
18 1053 4 4 8 50.0% 0.8%
19 1103 7 7 14 50.0% 1.4%
Previous HIV test
Not tested 2816 0 17 17 100.0% 0.7%
0–3 months 326 0 0 0 0.0%
4–6 months 274 0 2 2 100.0% 1.0%
7–9 months 181 0 0 0 0.0%
10–12 months 162 0 1 1 100.0% 0.8%
more than 12 months 635 23 1 24 4.2% 3.8%
Unknown 29 0 0 0 0.0%
Young adults aged 20-34 in HH ever
tested by CHiPs
No young adult tested 2062 14 9 23 39.1% 1.3%
1 young adult tested 1477 7 7 14 50.0% 1.0%
2 young adults tested 564 2 5 7 71.4% 1.4%
3 or more young adults tested 320 0 0 0 0.0%
Older adults aged 35 or older in HH
ever tested by CHiPs
No older adult tested 2212 15 13 28 46.4% 1.4%
1 older adult tested 1466 7 8 15 53.3% 1.1%
2 or more older adults tested 745 1 0 1 0.0% 0.1%
Known HIV-positive young
adults aged 20-34 in HH
No 4100 21 20 41 48.8% 1.1%
Yes 323 2 1 3 33.3% 1.0%
Known HIV-positive older adults
aged 35 or older in HH
No 3926 11 18 29 62.1% 0.9%
1 older adult HIV-positive 412 8 3 11 27.3% 2.9%
2 or more older adults HIV-positives 85 4 0 4 0.0% 4.7%
TB
Not symptomatic 4405 20 18 38 47.4% 1.0%
On treatment 1 0 0 0 0.0%
TB suspects 17 3 3 6 50.0% 38.2%
STI
Not symptomatic 4385 22 21 43 48.8% 1.1%
Symptomatic 22 1 0 1 0.0% 4.5%
Missing 16 0 0 0 0.0%
Circumcision
Not circumcised 2425 20 16 36 44.4% 1.6%
VMMC 1741 3 2 5 40.0% 0.3%
Traditional 138 0 2 2 100.0% 1.9%
Missing 119 0 1 1 100.0% 1.1%
CHiPs, community HIV care providers; HH, household; HIVþ, HIV positive; HIV-, HIV negative; STI, sexually transmitted infections; TB,
tuberculosis; VMMC, voluntary medical male circumcision.HIV-prevalence generalized epidemic, HB-HCT is accep-
table and feasible for adolescents and has made a significant
impact toward the first of UNAIDS 90–90–90 targets [2].
Our findings are consistent with prior research that shows
that high uptake of HCT among adolescents can be
achieved through home-base interventions [24]. In
Uganda, home-based family-centred HCT resulted in a
six times increase of HCTuptake among individuals aged6 to 14 years compared with that provided at clinics
[24,25]. Not only do home-based approaches achieve
high HCT uptake among adolescents, they also identify
individuals at early stage of their HIV infection, as they do
not rely on individuals presenting to health facilities with
symptoms [24].
We were not able to reach 27.7% of the enumerated
adolescents mostly because of absent rates especially
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Table 3. Self-reported HIV-positive and newly HIV-positive identified by community HIV care providers in adolescent females.
Characteristic
Total consented
to intervention
Self-reported
HIVþ
Tested
HIVþ
Known HIVþ after
the intervention
Proportion of HIVþ
diagnosed by CHiPs
HIVprevalence
among consenters
Total 6461 52 114 166 68.7% 3.0%
Community
Z2 855 5 14 19 73.7% 2.6%
Z5 1729 12 29 41 70.7% 2.5%
Z8 2924 25 57 82 69.5% 3.4%
Z10 953 10 14 24 58.3% 3.0%
Age
15 949 5 3 8 37.5% 1.0%
16 1204 7 15 22 68.2% 2.1%
17 1001 4 18 22 81.8% 2.6%
18 1620 10 43 53 81.1% 3.8%
19 1687 26 35 61 57.4% 4.1%
Previous HIV test
Not tested 3565 4 55 59 93.2% 2.0%
0–3 months 754 8 4 12 33.3% 2.0%
4–6 months 505 1 12 13 92.3% 3.0%
7–9 months 377 5 5 10 50.0% 2.9%
10–12 months 315 1 9 10 90.0% 3.7%
more than 12 months 926 33 29 62 46.8% 7.2%
Unknown 19 0 0 0 0.0%
Missing
Young adults aged 20-34 in HH ever tested by CHiPs
No young adult tested 3156 30 56 86 65.1% 3.3%
1 young adult tested 2186 16 41 57 71.9% 3.0%
2 young adults tested 754 3 13 16 81.3% 2.3%
3 or more young adults tested 365 3 4 7 57.1% 2.1%
Older adults aged 35 or older in HH ever tested by CHiPs
No older adult tested 3759 32 73 105 69.5% 3.3%
1 older adult tested 1826 13 26 39 66.7% 2.4%
2 or more older adults tested 876 7 15 22 68.2% 2.8%
Known HIV-positive young adults aged 20-34 in HH
No 5949 38 100 138 72.5% 2.7%
Yes 512 14 14 28 50.0% 5.9%
Known HIV-positive older adults aged 35 or older in HH
No 5846 40 99 139 71.2% 2.8%
1 older adult HIV-positive 501 8 12 20 60.0% 4.5%
2 or more older adults HIV-positive 114 4 3 7 42.9% 6.9%
TB
Not symptomatic 6427 48 107 155 69.0% 2.8%
On treatment 5 0 0 0 0.0%
TB suspects 29 4 7 11 63.6% 40.0%
Pregnant
No 6049 48 96 144 66.7% 2.8%
Yes 375 4 16 20 80.0% 6.3%
Missing 37 0 2 2 100.0% 7.1%
STI
Not symptomatic 6379 50 103 153 67.3% 2.8%
Symptomatic 61 2 11 13 84.6% 22.3%
Missing 21 0 0 0 0.0%
CHiPs, community HIV care providers; HH, household; HIVþ, HIV positive; HIV-, HIV negative; STI, sexually transmitted infections, TB,
tuberculosis.among males and younger age groups. For such harder-
to-access groups, HB-HCT can be implemented along-
side other methods that have been demonstrated to
increase testing rates, including provider initiated testing
and counselling [26], adolescent-friendly healthcare
facilities [21], social marketing campaigns [27], mobile
testing [28] as well as self-testing [29]. A systematic
review, investigating acceptability of HCT in individuals
aged 5–19 years in SSA found that provider initiated
testing and counselling achieved the highest acceptability
(86%), followed by HB-HCT (84.9%) but rates werelower for school-linked HCT (60.4%) and family-centred
approaches (51.7%) [24].
Although HCT uptake was similar by sex, HIV
prevalence was higher in females compared with males,
as observed elsewhere [10,30–32]. Adolescent girls have
earlier sexual debut than boys because of factors such as
intergenerational sex [31], gender-based violence,
economic dependency, and low ability to negotiate
condom use [33,34]. This has implications for future
interventions which need to prioritize adolescent girls.
S230 AIDS 2017, Vol 31 (Suppl 3)
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Fig. 3. (a) Proportion of HIV-positive adolescent males that
know their status ‘‘First 90’’ (b) Proportion of HIV-positive
adolescent females that know their status ‘‘First 90’’.Factors associated with uptake of home-based
HIV counselling and testing
Several factors at individual, household and community
levels have been associated with HCT uptake [39].
Although these are widely acknowledged in adults,
evidence is limited for adolescents. We found that HCT
uptake was associated with age, community, duration
since previous HIV test, having young adults in the
household previously tested by CHiPs, being sympto-
matic for STIs, VMMC and having a known HIV-
positive adult in the household.
Increasing age corresponded with increasing HCTuptake
partly because of 15–17 years olds being less regularly
found at home compared with 18–19 years old because of
school attendance [9]. This raises the potential role of
testing these young adolescents through other sources.
Furthermore, the refusal rate among 15 year olds was
particularly high. The age of consent for HCT services in
Zambia is 16 years [35]; those younger encountered more
obstacles to HCTaround obtaining parental consent. This
supports the need to engage parents and increase their
awareness of the benefits of HCT [21,36]. The younger
adolescent found to be HIV positive are most likely to
have been perinatally infected, and although the relative
numbers are thought to be small, may represent a specificgroup to target for alternative routes of offering testing,
for example through parents’ ART clinics.
Contextual factors have been shown to influence uptake
of interventions like HCT. Detailed description of
contextual differences in our communities is described
elsewhere [23]. High levels of HIV sensitization programs
conducted by non-governmental organizations have been
observed in community Z5, potentially contributing to
the high HCTuptake [23]. Community Z5 is dominated
by a largely informal sector, where access to clinics and
services may be limited because of poverty and testing
options situated outside the community [23].
Interestingly, we show that household composition
influences HCT uptake. In females, having an HIV-
positive household member (young or older adult) was
associated with higher HCTuptake and to our knowledge
has not been demonstrated before in this age group. This
finding supports the need for intensifying HIV index case
testing for adolescents in households that have an HIV-
positive adult. Index case testing of individuals receiving
any HIV care or treatment service has been recom-
mended, either through facilities or home based [37]. In
adults, index testing has been effective through assisted
partner notification services [38–40]. In children, index
case testing has been shown to have a 10-fold increase in
the identification and enrolment of HIV-infected
children into paediatric care and treatment services
[41]. However, there is little known about the feasibility
of index case testing amongst adolescents. This finding
emphasises the potential role index case testing could have
among adolescents, and the need for further research.
In this study, the intervention increased opportunities to
engage and influence other family members as adolescents
living in households with at least an additional member
previously tested by CHiPs had higher odds of accepting
HCT; as reported elsewhere [15].
Although few adolescents reported STI symptoms,
females symptomatic for STIs were more likely to test
for HIV. Previous research on this is mixed: in Mwanza,
Tanzania, STI symptoms did not correlate with HCT
uptake [42], whereas another study in Tanzania showed
an association between testing uptake and STI symptoms
[43]. These mixed results may be because of the
challenging nature of self-reporting of STI symptoms
and the perceived increased risk of HIVacquisition. Males
who had received VMMC had higher HCT uptake; it is
hypothesized that individuals who are more likely to have
VMMC may be more willing to accept medical
interventions, including HCT.
Limitations
In this study, ‘first 90’ was not quite reached partly
because of challenges around parental consent; parents
were often not found at home, or were not willing to
Adolescents’ HIV status knowledge Shanaube et al. S231provide consent for younger adolescents. The interven-
tion is resource intensive and the overall cost-effectiveness
will not be available until completion of the main trial. It
may be more feasible to deliver streamlined and targeted
youth-friendly approaches for different age bands and sex
similar to index-case based testing programs [37].
Furthermore, data was only analysed from the interven-
tion arm A communities, without comparison with the
control communities, where data is not yet available.
However, as the majority of adolescents tested through
the intervention, we feel confident in attributing the large
rise in HCT to the intervention.Conclusion
Through a home-based approach of offering a combi-
nation HIV prevention package the proportion of
adolescents who knew their HIV status increased from
28 to 89%, approaching the target goal of 90%. This
study provides strong evidence that HB-HCT is feasible,
acceptable and effective at significantly increasing HCT
uptake among adolescents aged 15–19. HB-HCT is an
effective intervention to increase the uptake of the first of
UNAIDS 90–90-90 targets amongst adolescents and
could be particularly effective if implemented in
combination with targeted testing.Acknowledgements
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